Screener
Neurocrine Biosciences NBIX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's net margin?
- Neurocrine Biosciences (NBIX) reported net margin of 21.6% in Q1 2026.
- How has Neurocrine Biosciences's net margin changed year-over-year?
- Neurocrine Biosciences's net margin increased by 70.0% year-over-year, from 12.7% to 21.6%.
- What is the long-term trend for Neurocrine Biosciences's net margin?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's net margin has grown at a -15.5% compound annual growth rate (CAGR), from 38.9% to 16.7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Neurocrine Biosciences's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude